{
    "Trade/Device Name(s)": [
        "SMARTLYTE Electrolyte Analyzer"
    ],
    "Submitter Information": "Diamond Diagnostics",
    "510(k) Number": "K121040",
    "Predicate Device Reference 510(k) Number(s)": [
        "K961458",
        "K082462"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JGS",
        "CEM",
        "CGZ",
        "JFP",
        "JIH"
    ],
    "Summary Letter Date": "August 2, 2012",
    "Summary Letter Received Date": "August 3, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1665",
        "21CFR862.1600",
        "21CFR862.1170",
        "21CFR862.1145",
        "21CFR862.3560"
    ],
    "Regulation Name(s)": [
        "Sodium test system",
        "Potassium test system",
        "Chloride test system",
        "Calcium test system",
        "Lithium test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "Sodium",
        "Potassium",
        "Chloride",
        "Calcium",
        "Lithium"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Whole Blood",
        "Urine",
        "Dialysate",
        "Aqueous QC"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "SMARTLYTE Electrolyte Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Ion-selective electrode (ISE)",
        "Microprocessor-controlled analyzer"
    ],
    "Methodologies": [
        "Potentiometry",
        "Automated ion-selective electrode testing"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Assay",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for SMARTLYTE Electrolyte Analyzer using ion-selective electrodes for measurement of sodium, potassium, chloride, calcium, and lithium in various clinical specimens and dialysate.",
    "Indications for Use Summary": "Measures sodium, potassium, chloride, calcium, and lithium in serum, plasma, whole blood, urine, and dialysate to aid diagnosis and treatment of electrolyte and metabolic disorders, bone disease, renal disease, and for lithium monitoring in psychiatric treatment.",
    "fda_folder": "Clinical Chemistry"
}